Impact of BA.1, BA.2, and BA.4/BA.5 Omicron Mutations on Therapeutic Monoclonal Antibodies
B. Jawad, P. Adhikari, R. Podgornik, W.-Y. Ching
This study uses molecular dynamics simulations to assess how Omicron subvariant mutations affect binding to therapeutic monoclonal antibodies, finding significant loss of activity for most mAbs.
bioRxiv · Dec 25, 2022Biophysics